Los Gatos, CA – According to filings with the U.S. Securities and Exchange Commission, Evanostics is raising $2,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Ashutosh Shastry played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Evanostics

Evanostics is a Silicon-Valley-based start-up founded by engineers and toxicologists in 2016 with a mission to save human lives and improve patient care by simplifying diagnostics making it easy, fast and accurate. Evanostics’ vision is to create the thermometer for diagnostic testing. Evanostics is privately funded. The company is currently closing an investment round to launch its first products. The Evanostics point-of-care diagnostic platform provides healthcare professionals with easy, fast, and accurate results, enabling critical, timely doctor-patient discussions and sound decisions. The platform works with small volumes of saliva or blood. The system is extremely easy to use, requiring minimal training. Accurate test results are available in 15 minutes, while the patient is still at the clinic. Results can be transferred to the patient’s electronic medical records or uploaded to the cloud, enabling physicians to review the information remotely.

To learn more about Evanostics, visit http://www.evanostics.com/

Contact:
Ashutosh Shastry, President and Chief Executive Officer
650-308-4154
ashastry@evanostics.com
https://www.linkedin.com/in/ashutoshshastry/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved